Methylphenidate-induced psychosis in adult attention-deficit/hyperactivity disorder: Report of 3 new cases and review of the literature

Clinical Neuropharmacology

Volumn 33, Issue 4, 2010, Pages 204-206

  Kraemer, Markus ^a,b   Uekermann, Jennifer ^a   Wiltfang, Jens ^a   Kis, Bernhard ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b ALFRIED KRUPP KRANKENHAUS   (Germany)

Author keywords

adult attention deficit hyperactivity disorder; methylphenidate; psychosis

Indexed keywords

ATOMOXETINE; METHYLPHENIDATE; OLANZAPINE; PALIPERIDONE; RISPERIDONE;

ADULT; ATTENTION DEFICIT DISORDER; CASE REPORT; DELUSION; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG OVERDOSE; DRUG WITHDRAWAL; FEMALE; HUMAN; ILLUSION; MALE; OLFACTORY HALLUCINATION; PANIC; PARANOIA; PRIORITY JOURNAL; PSYCHOLOGIC TEST; PSYCHOSIS; PSYCHOSOCIAL DISORDER; RESTLESSNESS; REVIEW; SLEEP DISORDER;

ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BIPOLAR DISORDER; CENTRAL NERVOUS SYSTEM STIMULANTS; FEMALE; HUMANS; MALE; METHYLPHENIDATE; MIDDLE AGED; PSYCHOSES, SUBSTANCE-INDUCED; SCHIZOPHRENIA; SUBSTANCE-RELATED DISORDERS;

EID: 77955176002     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNF.0b013e3181e29174     Document Type: Review

References (21)

1. Jolin EM, Weller RA, Jessani NR, et al. Affective disorders and other psychiatric diagnoses in children and adolescents with 22q11.2 deletion syndrome. J Affect Disord 2009;119(1-3):177-180
2. Jolin EM, Weller RA, Weller EB. Psychosis in children with velocardiofacial syndrome (22q11.2 deletion syndrome). Curr Psychiatry Rep 2009;11:99-105.
3. Leong GB, Shaner AL, Silva JA. Narcolepsy, paranoid psychosis, and analeptic abuse. Psychiatr J Univ Ott 1989;14:481-83.
4. Berman SM, Kuczenski R, McCracken JT, et al. Potential adverse effects of amphetamine treatment on brain and behavior: a review Mol Psychiatry 2009;14:123-142.
5. Kishi Y, Konishi S, Koizumi S, et al. Schizophrenia and narcoleps a review with a case report. Psychiatry Clin Neurosci 2004;58: 117-124.
6. Auger RR, Goodman SH, Silber MH, et al. Risks of high-dose stimulants in the treatment of disorders of excessive somnolence: a case-control study. Sleep 2005;28:667-672.
7. Marsh PJ, Williams LM. ADHD and schizophrenia phenomenology: visual scan paths to emotional faces as a potential psychophysiological marker? Neurosci Biobehav Rev 2006; 30:651-665.
8. Spensley J. Folie a deux with methylphenidate psychosis. JNerv Ment Dis 1972;155:288-290.
9. Spensley J, Rockwell DA. Psychosis during methylphenidate abuse. N Engl J Med 1972;286:880-881.
10. Barrett SP, Darredeau C, Bordy LE, et al. Characteristics of methylphenidate misuse in a university student sample. Can J Psychiatry 2005;50:457-461.
11. Wilens TE. Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues. Psychiatr Clin North Am 2004;27:283-301.
12. Wilens TE. Impact of ADHD and its treatment on substance abuse in adults. J Clin Psychiatry 2004;65(suppl 3):38-45.
13. Pine DS, Klein RG, Lindy DC, et al. Attention-deficit hyperactivity disorder and comorbid psychosis: a review and two clinical presentations. J Clin Psychiatry 1993;54:140-145.
14. Young JG. Methylphenidate-induced hallucinosis: case histories and possible mechanisms of action. J Dev Behav Pediatr 1981;2: 35-38.
15. Ross RG. Psychotic and manic-like symptoms during stimulant treatment of attention deficit hyperactivity disorder. Am J Psychiatry 2006;163:1149-1152.
16. Greiner C, Enss E, Haen E. Drug-induced psychosis after intake of a modified-release formulation of methylphenidate [in German]. Psychiatr Prax 2009;36:89-91.
17. Caci H, Bayle F. A case of disulfiram-methylphenidate interaction: implications for treatment. Am J Psychiatry 2007;164:1759.
18. Yamamoto K, Cubells JF, Gelernter J, et al. Dopamine beta-hydroxylase (DBH) gene and schizophrenia phenotypic variability: a genetic association study. Am J Med Genet B Neuropsychiatr Genet 2003; 117B:33-38.
19. Seeman P, Schwarz J, Chen JF, et al. Psychosis pathways converge via D2high dopamine receptors. Synapse 2006;60:319-346.
20. Seeman P, Weinshenker D, Quirion R, et al. Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis. Proc Natl Acad Sci USA 2005;102:3513-3518.
21. Mehler-Wex C, Riederer P, Gerlach M. Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder. Neurotox Res 2006;10:167-179.